{
  "variants": [
    {
      "variant_string_id": "LRRK2 Y1699C",
      "gene": "LRRK2",
      "protein_change": {
        "ref": "Y",
        "alt": "C",
        "position": 1699
      },
      "functional_evidence_steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism.",
          "judgment": "Yes",
          "reason": "The mutation is pathogenic, and the study shows decreased GTPase activity due to altered dimerization and intra-molecular ROC:COR interaction."
        },
        {
          "step": 2,
          "description": "Evaluate applicability of assay class.",
          "judgment": "Yes",
          "reason": "GTPase activity and dimerization assays directly model the disease mechanism."
        },
        {
          "step": 3,
          "description": "Basic Controls and Replicates.",
          "judgment": "Not explicitly met",
          "reason": "The paper compares Y1699C to R1441C (pathogenic) and T1348N (dysfunctional), but does not explicitly mention wild-type or empty vector controls."
        },
        {
          "step": 3,
          "description": "Variant Controls (if basic controls/replicates were sufficient).",
          "judgment": "Yes",
          "reason": "Known pathogenic (R1441C) and dysfunctional (T1348N) variants are used as controls."
        },
        {
          "step": 4,
          "description": "Apply evidence to individual variant interpretation.",
          "judgment": "Max PS3_supporting",
          "reason": "Known variant controls are used, and statistical analyses are insufficient."
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_string_id": "LRRK2 R1441C",
      "gene": "LRRK2",
      "protein_change": {
        "ref": "R",
        "alt": "C",
        "position": 1441
      },
      "functional_evidence_steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism.",
          "judgment": "Yes",
          "reason": "The mutation is pathogenic, and the study shows decreased GTPase activity compared to Y1699C and T1348N."
        },
        {
          "step": 2,
          "description": "Evaluate applicability of assay class.",
          "judgment": "Yes",
          "reason": "GTPase activity and dimerization assays directly model the disease mechanism."
        },
        {
          "step": 3,
          "description": "Basic Controls and Replicates.",
          "judgment": "Not explicitly met",
          "reason": "The paper compares R1441C to Y1699C (pathogenic) and T1348N (dysfunctional), but does not explicitly mention wild-type or empty vector controls."
        },
        {
          "step": 3,
          "description": "Variant Controls (if basic controls/replicates were sufficient).",
          "judgment": "Yes",
          "reason": "Known pathogenic (Y1693C) and dysfunctional (T1348N) variants are used as controls."
        },
        {
          "step": 4,
          "description": "Apply evidence to individual variant interpretation.",
          "judgment": "Max PS3_supporting",
          "reason": "Known variant controls are used, and statistical analyses are insufficient."
        }
      ],
      "strength": "PS3_supporting"
    },
    {
      "variant_string_id": "LRRK2 T1348N",
      "gene": "LRRK2",
      "protein_change": {
        "ref": "T",
        "alt": "N",
        "position": 1348
      },
      "functional_evidence_steps": [
        {
          "step": 1,
          "description": "Define the disease mechanism.",
          "judgment": "Yes",
          "reason": "The mutation is described as dysfunctional, indicating impaired function."
        },
        {
          "step": 2,
          "description": "Evaluate applicability of assay class.",
          "judgment": "Yes",
          "reason": "Dysfunction is modeled through reduced activity in assays."
        },
        {
          "step": 3,
          "description": "Basic Controls and Replicates.",
          "judgment": "Not explicitly met",
          "reason": "The paper does not explicitly mention wild-type or empty vector controls."
        },
        {
          "step": 3,
          "description": "Variant Controls (if basic controls/replicates were sufficient).",
          "judgment": "Yes",
          "reason": "Known pathogenic (R1441C) and functional variants are used as controls."
        },
        {
          "step": 4,
          "description": "Apply evidence to individual variant interpretation.",
          "judgment": "Max BS3_supporting",
          "reason": "Known variant controls are used, and statistical analyses are insufficient."
        }
      ],
      "strength": "BS3_supporting"
    }
  ]
}